A priori molecular descriptors in QSAR: a case of HIV-1 protease inhibitors. I. The chemometric approach.

J Mol Graph Model

Instituto de Química, Universidade Estadual de Campinas, Campinas, SP 13083-970, Brazil.

Published: March 2003

AI Article Synopsis

  • A QSAR study was conducted on 48 peptidic HIV-1 protease inhibitors using 14 molecular descriptors to develop predictive models.
  • Two PLS models were created, with one showing a strong correlation to literature models (r²=0.91, q²=0.84), highlighting the effectiveness of the descriptors used.
  • Cluster and principal component analyses classified the inhibitors' activity levels and identified key components related to enzyme-inhibitor binding.

Article Abstract

A quantitative structure-activity relationship (QSAR) study on 48 peptidic HIV-1 protease inhibitors was performed. Fourteen a priori molecular descriptors were used to build QSAR models. Hierarchical cluster analysis (HCA), principal component analysis (PCA) and partial least squares (PLS) regression were employed. PLS models with 32/16 (model I) and 48/0 (model II) molecules in the training/external validation set were constructed. The a priori molecular descriptors were related to two energetic variables using PLS. HCA and PCA on data from model II classified the inhibitors as slightly, moderately and highly active; three principal components, the chemical nature of which has been highlighted, are enough to describe the enzyme-inhibitor binding. Model I (r(2)=0.91, q(2)=0.84) is comparable to literature models obtained by various QSAR softwares, which justified the use of a priori descriptors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1093-3263(02)00201-2DOI Listing

Publication Analysis

Top Keywords

priori molecular
12
molecular descriptors
12
hiv-1 protease
8
protease inhibitors
8
priori
4
descriptors
4
qsar
4
descriptors qsar
4
qsar case
4
case hiv-1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!